Chemed (CHE) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Chemed

NYSE•Healthcare•Medical Care Facilities

$515.97+1.57(<0.01%)Market closed

Market Cap

$6.64B

P/E

24.1x

P/S

2.6x

P/B

8.0x

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

How this company scores

GoodMetricSide Score: 68/100

Strongest: Balance Sheet & Red Flags (20/25); weakest: Growth (13/25).

Profitability17/25

Growth13/25

Balance Sheet & Red Flags20/25

Cash & Earnings Quality18/25

Strengths

High ROELow leverageInterest easily coveredCash-backed earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 24.1x5y range 19.7x – 35.6x

Currently near its 20-quarter median.

P/S · 2.6x5y range 2.0x – 4.2x

Currently below its 20-quarter median.

P/B · 8.0x5y range 5.9x – 13.0x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Margin Pressure

Watch

Operating margins declined 8.2% — watch for continued compression, which may signal competitive or cost pressure.

Price & Volume

Market Cap $6.64B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $2.60B
Q. Revenue: $673.25M
TTM EBITDA: $415.61M
TTM Op. Income: $349.19M
Q. Op. Income: $89.20M
TTM Net Income: $274.99M
Q. Net Income: $67.70M
EPS: $5.14
Shares Out.: $13.17M

$2.60B in TTM revenue grew 3.3% YoY, reaching $673.25M last quarter. TTM EBITDA of $415.61M and TTM operating income of $349.19M show growth is flowing through to the bottom line. TTM net income of $274.99M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 2 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 32.9%
EBITDA Margin: 15.8%
Op. Margin: 13.2%
Net Margin: 10.1%

Op. margin of 13.2% is up 2.2% YoY — cost efficiency is improving. Net margin at 10.1% and gross margin of 32.9% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 20% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 24.1x
P/S Ratio: 2.6x
P/B Ratio: 8.0x

At 24.1x P/E, the stock trades within typical market levels. P/S of 2.6x and P/B of 8.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 1% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.58B
Cash: $40.22M
Long-Term Debt: $140.00M
Book Value: $830.51M
D/E Ratio: 0.2
Debt/EBITDA: 1.3

With $1.58B in assets and $140.00M in long-term debt, D/E is 0.2and book value is $830.51M — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is up 0% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $84.81M
TTM Free Cash Flow: $323.61M
FCF Margin: 12.5%
FCF / Net Income: 1.2

TTM FCF of $323.61M on $84.81M in operating cash flow. The FCF / Net Income ratio of 1.2x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is down 13% — a weakening trend.